Kolexia
Despas Fabien Pharmacien
Despas Fabien
Pharmacien
Hôpital Hôtel-Dieu Saint-Jacques
Toulouse, France
189 Activités
178 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Leucémies Défaillance cardiaque Leucémie myéloïde chronique BCR-ABL positive Effets secondaires indésirables des médicaments Leucémie myéloïde Lymphome B Lymphome B diffus à grandes cellules Myélome multiple

Collaborateurs

Voir plus
Lapeyre-Mestre Maryse
Lapeyre-Mestre Maryse
Hôpital Purpan, Toulouse, France
Pathak Atul
Pathak Atul
Cabinet libéral, Toulouse, France
Laurent Guy
Laurent Guy
Oncopole Toulouse, Toulouse, France
Senard Jean-Michel
Senard Jean-Michel
Fac. Medecine Depart. Epidemio, Toulouse, France

Industries

Voir plus
Abbvie
1 collaboration(s)
Dernière en 2021
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Deleterious association between proton pump inhibitor and protein kinase inhibitor exposure and survival for patients with lung cancer: A nationwide cohort study.
Cancer treatment and research communications   29 février 2024
Teaching pharmacovigilance to French medical students during the COVID-19 pandemic: Interest of distance learning clinical reasoning sessions.
Therapie   12 janvier 2024
Transfusion needs after CAR T-cell therapy for large B-cell lymphoma: predictive factors and outcome. A DESCAR-T study.
Blood advances   04 janvier 2024
Drug-induced tumoral disease: A global pharmacovigilance database analysis.
Therapie   18 novembre 2023
Transfusion needs after CD19 CAR T-cells for large B-cell lymphoma: predictive factors and impact on outcome. A DESCAR-T study.
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023
Drug-drug interactions of protein kinase inhibitors in chronic myeloid leukaemia patients: A study using the French health insurance database.
Fundamental & clinical pharmacology   24 avril 2023
Abstract 3203: EVOcells Oncology: Tailored genetic engineering of iPSC-derived immune effector cells and combination with the right biologic therapeutics result in optimal killing of primary tumor cells from patients
Proceedings: AACR Annual Meeting 2023   01 avril 2023
Incidence of heart failure following exposure to a protein kinase inhibitor, a French population-based study.
British journal of clinical pharmacology   13 novembre 2022
How does head position induced intracranial pressure changes impact sympathetic activity and cerebral blood flow?
Autonomic neuroscience : basic & clinical   24 septembre 2022
Impact de la prise en charge de la leucémie myéloïde chronique par les médicaments inhibiteurs des protéines kinases sur l’activité professionnelle
COVID-19   01 août 2022